Page last updated: 2024-11-02

oxidopamine and Adrenal Cancer

oxidopamine has been researched along with Adrenal Cancer in 6 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Guo, L1
Qu, B1
Song, C1
Zhu, S1
Gong, N1
Sun, J1
Mei, JM1
Niu, CS1
Snavely, MD1
Motulsky, HJ1
Moustafa, E1
Mahan, LC1
Insel, PA1
Matthew, WD1
Patterson, PH1
Decker, DE1
Althaus, JS1
Buxser, SE1
VonVoigtlander, PF1
Ruppel, PL1
Gassen, M1
Pinchasi, B1
Youdim, MB1

Other Studies

6 other studies available for oxidopamine and Adrenal Cancer

ArticleYear
Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a/PI3K/Akt/mTOR signaling pathways in differentiated rat pheochromocytoma cells.
    Journal of affective disorders, 2022, 11-01, Volume: 316

    Topics: Adrenal Gland Neoplasms; Animals; Apoptosis; MicroRNAs; Neuroprotective Agents; Oxidopamine; Parkins

2022
Effects of CDNF on 6-OHDA-induced apoptosis in PC12 cells via modulation of Bcl-2/Bax and caspase-3 activation.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014, Volume: 35, Issue:8

    Topics: Adrenal Gland Neoplasms; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Dopaminergic Neu

2014
beta-Adrenergic receptor subtypes in the rat renal cortex. Selective regulation of beta 1-adrenergic receptors by pheochromocytoma.
    Circulation research, 1982, Volume: 51, Issue:4

    Topics: Adrenal Gland Neoplasms; Animals; Binding, Competitive; Epinephrine; Hydroxydopamines; Iodocyanopind

1982
The production of a monoclonal antibody that blocks the action of a neurite outgrowth-promoting factor.
    Cold Spring Harbor symposia on quantitative biology, 1983, Volume: 48 Pt 2

    Topics: Adrenal Gland Neoplasms; Animals; Antibodies, Monoclonal; Axons; Cell Line; Cyclophosphamide; Fluore

1983
Competitive irreversible inhibition of dopamine uptake by 6-hydroxydopamine.
    Research communications in chemical pathology and pharmacology, 1993, Volume: 79, Issue:2

    Topics: Adrenal Gland Neoplasms; Aminoisobutyric Acids; Animals; Binding, Competitive; Biological Transport;

1993
Apomorphine is a potent radical scavenger and protects cultured pheochromocytoma cells from 6-OHDA and H2O2-induced cell death.
    Advances in pharmacology (San Diego, Calif.), 1998, Volume: 42

    Topics: Adrenal Gland Neoplasms; Animals; Apomorphine; Cell Death; Free Radical Scavengers; Hydrogen Peroxid

1998